Skip to main content

Peer Review reports

From: Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context

Original Submission
19 Dec 2017 Submitted Original manuscript
9 Jan 2018 Reviewed Reviewer Report - Taichi Hikichi
19 Jan 2018 Author responded Author comments - Martin K. Schmid
19 Jan 2018 Reviewed Reviewer Report - Harumasa Yokota
Resubmission - Version 2
19 Jan 2018 Submitted Manuscript version 2
13 Feb 2018 Author responded Author comments - Martin K. Schmid
Resubmission - Version 3
13 Feb 2018 Submitted Manuscript version 3
Publishing
23 Feb 2018 Editorially accepted
27 Feb 2018 Article published 10.1186/s12886-018-0731-4

You can find further information about peer review here.

Back to article page